Contents

Search


autoimmune bullous disease (... pemphigus, bullous pemphigoid)

Etiology: - bullous pemphigoid - cicatricial pemphigoid - epidermolysis bullosa acquisita - pemphigus - paraneoplastic pemphigus - linear IgA bullous dermatosis Clinical manifestations: - persistent pruritic to painful blisters &/or bullae - variable mucosal & ocular involvement - scarring is variable Laboratory: - skin biopsy - direct immunofluorescence testing of perilesional skin - histopathology of lesional skin - see ARUP consult [4] (Algorithm) Management: - immunosuppressants [1] - rituximab may be of benefit at a cost of serious adverse events [5]

Interactions

disease interactions

Specific

epidermolysis bullosa acquisita (EBA) linear IgA bullous dermatosis (IgA pemphigoid) pemphigoid pemphigus

General

autoimmune disease chronic skin disease (chronic dermatologic disorder, chronic dermatopathy, chronic dermatosis) vesiculobullous dermatitis

References

  1. Medical Knowledge Self Assessment Program (MKSAP) 16, 17, 18. American College of Physicians, Philadelphia 2012, 2015, 2018.
  2. Parker SR, MacKelfresh J. Autoimmune blistering diseases in the elderly. Clin Dermatol. 2011 Jan-Feb;29(1):69-79 PMID: 21146735
  3. Schmidt E, Zillikens D. Modern diagnosis of autoimmune blistering skin diseases. Autoimmun Rev. 2010 Dec;10(2):84-9 PMID: 20713186
  4. ARUP consult Immunobullous Skin Diseases Testing - Cancer https://arupconsult.com/algorithm/porphyrias-testing-algorithm Immunobullous Skin Diseases Testing - Pregnancy https://arupconsult.com/algorithm/immunobullous-disease-testing-algorithm-pregnancy
  5. Schmidt E, Brocker EB, Goebeler M. Rituximab in treatment-resistant autoimmune blistering skin disorders. Clin Rev Allergy Immunol. 2008 Feb;34(1):56-64 PMID: 18270859